Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Receiving Antimicrobial Therapy”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Not applicableNot Yet RecruitingNCT06319677
What this trial is testing

PK/PD Study of Anti-Infective Drugs in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Treatment

Who this might be right for
Critical IllnessExtracorporeal Membrane Oxygenation Complication
The Third Xiangya Hospital of Central South University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602557
What this trial is testing

" a Randomized Pilot Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation (ECMO-VA)."

Who this might be right for
Pneumonia, BacterialExtracorporeal Membrane Oxygenation
Assistance Publique - Hôpitaux de Paris 26
Large-scale testing (Phase 3)Study completedNCT01513239
What this trial is testing

MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,203
Post-approval studies (Phase 4)Study completedNCT02692651
What this trial is testing

A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections

Who this might be right for
Clostridium Difficile Infection (CDI)
University of Michigan 144
Not applicableWithdrawnNCT02242721
What this trial is testing

Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)

Who this might be right for
Need for Renal Replacement Therapy and Anti-infective Therapy Due to Severe Infection
Charite University, Berlin, Germany
Not applicableStudy completedNCT04440631
What this trial is testing

Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection

Who this might be right for
Fractures, BoneInfection, BacterialJoint Infection+1 more
AO Research Institute Davos 12
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Early research (Phase 1)Ended earlyNCT01522105
What this trial is testing

Daptomycin in Pediatric Patients With Bacterial Meningitis

Who this might be right for
Meningitis
Insel Gruppe AG, University Hospital Bern 1
Testing effectiveness (Phase 2)Study completedNCT00002170
What this trial is testing

Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Agouron Pharmaceuticals
Early research (Phase 1)Study completedNCT00136292
What this trial is testing

Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics

Who this might be right for
Gram-positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 33
Not applicableStudy completedNCT01136200
What this trial is testing

Impact of Infectious Diseases Specialists on the Appropriateness of Antimicrobial Therapy in Surgical and Medical Wards

Who this might be right for
Patients Receiving Antimicrobial Therapy
Henri Mondor University Hospital 264
Not applicableStudy completedNCT03599999
What this trial is testing

Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin

Who this might be right for
Bacterial Infection With One or More Extended Spectrum Betalactamases Remaining Susceptible to Temocillin
Centre Hospitalier Universitaire, Amiens 26
Not applicableNot Yet RecruitingNCT07167524
What this trial is testing

Evaluation of the Dialytic Clearance of the Combination of Peracillin and Tazobactam

Who this might be right for
SepsisSevere Bacterial Infections
University Hospital, Rouen 24
Post-approval studies (Phase 4)UnknownNCT04995133
What this trial is testing

Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.

Who this might be right for
Hospital InfectionMulti-antibiotic ResistanceCritically Ill
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Large-scale testing (Phase 3)Study completedNCT01241552
What this trial is testing

MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,452
Large-scale testing (Phase 3)Study completedNCT00002850
What this trial is testing

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

Who this might be right for
InfectionMultiple Myeloma
Gary Morrow 212
Large-scale testing (Phase 3)Ended earlyNCT04160468
What this trial is testing

Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
ContraFect 259
Early research (Phase 1)Study completedNCT02266706
What this trial is testing

Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)

Who this might be right for
Proven or Suspected Gram-negative Bacterial InfectionPeri-operative Prophylaxis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 43
Early research (Phase 1)Study completedNCT01893346
What this trial is testing

Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections

Who this might be right for
Systemic Infections
Pfizer 35